Fritextsökning
Innehållstyper
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
LEO Pharma - International Clinical Trial Manager
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Biomarkörer kan avgöra svårighetsgrad av astma
Forskare från Karolinska institutet har genom att studera urinprov kunnat diagnosticera svår astma.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Missnöjd med din julklappsslips? Här är våra läsetips
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Theranos-skandalen – så gick det till när Elizabeth Holmes lurade USA:s toppinvesterare
Biotechbolaget Theranos var ett av de mest hyllade amerikanska företagen och dess vd Elizabeth Holmes blev en av USA:s yngsta miljardärer. Men 2015 vände allt f...
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Ny vd för Pledpharma på plats
Nicklas Westerholm tillträder som verkställande direktör i läkemedelsutvecklande Pledpharma.
-
Ilya Pharma utvecklar behandling mot bieffekter av immunterapier mot cancer
Uppsalaföretaget Ilya Pharma planerar att inleda kliniska studier med sin läkemedelskandidat ILP100-Oral för patienter som drabbats av enterokolit, tunn- och tj...
-
Astrazeneca i nytt bioinformatiksamarbete
Använder data från kliniska studier för att individanpassa behandlingen av cancerpatienter.